New Jersey, United States - “Global Schizophrenia Drugs Market Insight, Forecast 2028” is recen
New Jersey, United States - The Global Postoperative Pain Therapeutics Market is comprehen
New Jersey, United States - The Global Autoinjectors Market is carefully researched in the
New Jersey, United States - The report named “Global Drug Discovery Market Insights, Forecast t
New Jersey, United States - The report offers an in-depth analysis of the Global Growth Hormone
New Jersey, United States - Verified Market Research has recently published a research report t
New Jersey, United States - The Global Personalized Medicine market is expected to grow at a si
Shares of Eli Lilly & Co. rallied 2.32% to $332.10 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...
DUBLIN--(BUSINESS WIRE)--Oct 14, 2022--
Even a percentage of the Alzheimer’s market could mean $7 billion for Biogen.
Could Vertex’s Nav1.8 blocker tap the elusive analgesic potential of voltage-gated sodium channels?
Inflation increased more than expected in September despite the rate hikes. The stubbornly high inflation cements the case for further hawkishness from the Fed. Amid rising recession worries, we think dividend stocks Eli Lilly (LLY), APA Corporation (APA), and Bluegreen Vacations (BVH), with stable…
Hint: It’s not coming from end investors, asset managers, or corporations.
Many people, including buisness magnate Elon Musk, have used a drug known as Wegovy to shed some weight or jumpstart their weight loss. Although it can be pricy.
The ruling has had widespread impacts on abortion access, healthcare, the midterm elections and more.
Sudo Bioscience emerged with $37 million in funding and four programs that address TYK2, a promising target for autoimmune diseases. Bristol Myers Squibb drug Sotyktu recently won the first FDA approval for a TYK2 inhibitor but Sudo claims its molecules have the potential to be best in this new drug…
The week in pharma: action, reaction and insight – week to September 30
Chantico Global’s Gina Sanchez is bullish on Eli Lilly’s obesity drug. She’s convinced the healthcare stock can stand the coming recession.
Anti-amyloid drugs only modestly slow down the progression of Alzheimer’s in APOE4 carriers and have no effect on non-carriers. Read what it means for Eli Lilly.
Two of these three stocks are already soaring this year.